Kuangli Bio-Tech Holdings Co., Ltd. (6431.TW) TAI

Currency In TWD

AD

Valuation

Market Cap2.51B
Enterprise Value2.79B
P/E Ratio-8.61
PEG Ratio-0.6
Price/Sales Ratio4.57
Price/Book Ratio3.31
Enterprise/Revenue5.36
Enterprise/EBITDA-24.75

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.52
Operating Margin-0.45
AD

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.34

Income Statement

Revenue377.03M
Revenue/Share3.7
Gross Profit70.41M
EBITDA-92.46M
Net Income-193.04M
Diluted EPS-2.07

Balance Sheet

Total Cash221.67M
Total Cash/Share2.26
Total Debt509.04M
Total Debt/Equity1.01
Current Ratio1.11
Book Value Per Share5.21

Price History

52-Week Change6.23
52-Week High32
52-Week Low15.5
Moving Average 50 Days18.47
Moving Average 200 Days21.73

Statistics

Average Volume91,889
Shares Outstanding97.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD